Tuberculosis in pediatric kidney transplant recipients: 35 years of experience

https://storage.unitedwebnetwork.com/files/1099/3510d8f7cbb842948904bb5107647a14.pdf
Tuberculosis in pediatric kidney transplant recipients: 35 years of experience
Vanesa
Fauda
Ana Lucia Saez saezanalucia@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Juan Ibañez drjpibanez@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Luz Bendersky luz.bendersky@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Ivanna Gardarian igardarian@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Nadia Marlen Ortiz ortiznadiam@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Claudia Yeneris claudiayeneris@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Cenith Contrera cenithmd2806@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Rocio Busolo rociobusolo@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Natalia Salazar nsalazarpineda@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
Marta Monteverde martamonteverde1@gmail.com Hospital Garrahan Nephrology, dialysis and kidney transplant Buenos Aires
 
 
 
 
 

Tuberculosis (TB) is an endemic disease in Argentina, with an incidence rate of  25.9 cases/100,000 inhabitants. Several studies report that kidney transplant (KT) recipients have  20 to 100 times higher risk of developing TB than the general population.


Objectives

1) To describe in a cohort of pediatric kidney transplant patients the cumulative incidence and incidence rate of TB, overall and in 2 periods: 1988-2000 (era1); 2001-2023 (era2); (From  2001, all rejection episodes were biopsy confirmed), time of appearance, and clinical characteristics. 2) To compare patient and graft survival in those with and without TB.

Observational, descriptive, retrospective study. Data were collected from medical records of all KT patients at Hospital J.P Garrahan, from December 12th, 1988 to October 30th, 2023  and from SINTRA registry.

Between December 15th, 1988 and October 30th, 2023, 1,075 children received a KT. TB was diagnosed in 13 of them. The cumulative incidence (CI) of TB during the entire follow-up was 1.21%, and the incidence rate was 1.2 episodes/100 patients/year (95% CI interval: 1.11-1.27). In era 1 the CI was 1.28%, and in era 2 it was 1,12% (p=0.89). Demographic data are shown in Table 1. The average time from transplant to diagnosis of TB was 53 months; only 1 patient was diagnosed with TB at the tenth month after transplant.


Pulmonary tuberculosis was the most frequent clinical manifestation (n=9), only one patient presented with isolated involvement of the skin. Two patients presented extrapulmonary manifestations: brain granuloma and chorioretinitis in one case, and intestinal involvement in the other. Symptoms were: fever (92%), weight loss (30.8%), asthenia (46.2%) and respiratory symptoms (76.9%).


The diagnosis was based on a positive microbiological culture; 12 patients received rifampicin (rifampicin sensitive)  and one to levofloxacin (rifampicin resistant); 84% received treatment with 4 drugs (isoniazid, rifampicin, pyrazinamide and ethambutol). Median time of  follow-up was 6.3 years (IQR: 4.6-11.8). No deaths, graft loss or rejection episodes were reported at this period. There were no significant differences neither in graft nor on patient survival  between those with and without TB (p=0.44) and p=(0.74) respectively.


The cumulative incidence in kidney transplant patients was higher than in the general population, similar to other published studies. Pulmonary tuberculosis was the most frequent clinical manifestation. There were no complications related to the kidney graft.

Suspicion, early diagnosis, close  follow-up, as well as contact study are a priority to avoid the spread of TB and ensure favorable results in this population.

E-Poster Format Requirements
  • PDF file
  • Layout: Portrait (vertical orientation)
  • One page only (Dim A4: 210 x 297mm or PPT)
  • E-Poster can be prepared in PowerPoint (one (1) PowerPoint slide) but must be saved and submitted as PDF file.
  • File Size: Maximum file size is 2 Megabytes (2 MB)
  • No hyperlinks, animated images, animations, and slide transitions
  • Language: English
  • Include your abstract number
  • E-posters can include QR codes, tables and photos